|ShilNepal Editorial
shilajit origins - pure Himalayan resin tin on neutral stone, editorial photo

The History of Shilajit: Names, Traditions and Early Research

Shilajit has been used under different names across a wide arc of Asia, from the Indian subcontinent through Tibet, Persia and Central Asia to Russia. A lot of what is written about its history is repeated marketing: "thousands of years", "a secret of the Himalayan monks". This page sticks to what published sources document: the word and what dictionaries say it means, the traditions that recorded it, the Soviet-era studies, and the point at which controlled human research actually began. Where we could not verify a claim from a primary source, we say so.

In this article

  1. Names and etymology
  2. What each tradition recorded
  3. Soviet-era studies
  4. Modern research timeline
  5. What we could not verify
  6. References

Key takeaways

  • Sanskrit dictionaries give the word as a compound of "rock" and "what conquers or excels", glossed as bitumen or "rock-overpowering". They do not give "destroyer of weakness", which appears to be a later gloss.
  • Shilajit-like materials are recorded in Ayurvedic and Siddha medicine (a review counts it in twenty classical formulations), in traditional Persian medicine (as bitumen or mumiai), in Tibetan medicine (Zhaxun) and in Kazakh medicine (Tasmayi).
  • Controlled human trials are recent: the earliest we found were published in 2010 and 2016. Older clinical reports exist, mostly Soviet-era and abstract-level only.

Names and etymology

The main Sanskrit form is shilajit (also written shilajatu, silajit). Dictionaries record it as a feminine noun meaning bitumen, built from shila (stone, rock) and jit ("what conquers or excels", per Apte's dictionary), with another dictionary (Shabda-Sagara) glossing it as "rock-overpowering" and citing earlier lexicographers (Amarasimha, Halayudha, Hemacandra). So the literal meaning is closer to "rock conqueror" or "mountain bitumen" than to the popular "destroyer of weakness" (see Why is shilajit called "destroyer of weakness"?). Other names reflect local traditions: mumijo, mumie or moomiyo in Russia and Central Asia (Stohs 2014), momiai or mumiai in Persian sources (Shahriari 2018), Zhaxun in Tibetan medicine (Ding 2020) and Tasmayi in Kazakh medicine (Kizaibek 2013). One consequence is that the same word has been applied to different materials, including an Antarctic seabird deposit (Aiello 2011) and, in a 1998 pharmaceutics paper, a plant gum (Shahjahan 1998). See also Shilajit and Digestion.

What each tradition recorded

Tradition Name What a source documents
Ayurveda and Siddha (India) Shilajit, shilajatu A review found it in twenty classical formulations and described it as a rasayana (rejuvenator), while noting little systematic scientific documentation (Wilson 2011)
Traditional Persian medicine Momiai, mumiai (bitumen) Cited in Avicenna's Canon, Razes, Aghili and later works; known especially as a remedy for digestive problems (Shahriari 2018)
Tibetan medicine Zhaxun A water extract used mainly for heat-related syndromes of the stomach, liver and kidney (Ding 2020)
Kazakh medicine Tasmayi Used for bone fracture and many inflammatory ailments (Kizaibek 2013)
Russia and Central Asia Mumie, mumijo Used for infectious diseases and as an immune stimulant and antiallergic in traditional preparations (Aiello 2011)

The pattern is consistent: bone and wound healing, digestion and general vitality are recurring uses. That a material appears in several traditions is evidence of long use, not evidence that it works. For the Ayurvedic framework see also Shilajit in Meditation and Spiritual Tradition.

Long use in many traditions is a historical fact. It is not a clinical result, and the earliest controlled human trials of shilajit are less than twenty years old.

Soviet-era studies

PubMed indexes a cluster of Russian-language reports on mumie from 1965 to 1988, with titles such as the effect of mumie on bone regeneration in experimental fractures (1965), on lymphopoiesis in acute radiation sickness (1968), on bone regeneration in patients after surgery for osteoarticular tuberculosis (1972), on treatment of long bone fractures (1973), on healing of suppurative wounds (1987) and as an agent in tuberculosis treatment (1988). We have read only the titles and, where present, English abstracts, and most are not available in English, so we cannot judge their design or quality. They show that mumie was clinically studied in Central Asia and the Soviet Union for bone and wound problems decades before the modern trials, and they are consistent with the later tibial fracture trial (Sadeghi 2020; see Shilajit and Joint Pain).

Modern research timeline

Year Development
1965 to 1988 Russian-language studies on bone, wounds, radiation and tuberculosis
1976 Chemical constituents paper in the "Shilajit I" series (Ghosal 1976)
1990 Rat anti-ulcer and anti-inflammatory study (Goel 1990)
2003 to 2009 Fractionation of mumie and shilajit into fulvic and humic fractions, complement and immune cell work (Schepetkin 2003; 2009)
2007 and 2011 Reviews: Agarwal 2007; Wilson 2011
2010 Uncontrolled human study in oligospermia (Biswas 2010)
2016 First placebo-controlled testosterone trial in healthy men (Pandit 2016); muscle gene expression study (Das 2016)
2019 to 2022 Skin, muscle fatigue, fracture and bone density trials (Das 2019; Keller 2019; Sadeghi 2020; Pingali 2022)
2024 to 2026 Collagen marker trial, safety and contaminant studies, resin pilot (Neltner 2024; Hussain 2024; Yadav 2026)

The current picture is in our evidence review and Shilajit Benefits and Uses.

What we could not verify

  • Specific classical texts and dates. Shilajit is commonly said to appear in the Charaka Samhita and Sushruta Samhita. We have not checked the Sanskrit passages or editions ourselves in this rewrite, so we do not give passage references or dates.
  • "Thousands of years". A review states it has been used as a rejuvenator and adaptogen for thousands of years (Agarwal 2007), a statement from the literature that we have not independently dated.
  • Brand origin stories. A specific seller's account of family harvesting or monastery use is a marketing claim, not history, unless independently verifiable.

Lab results, batch #1093

History is not a lab report

Batch #1093 had heavy metals independently tested by Eurofins Food Australia, and the results are public.

Read the batch #1093 report

A lab report describes one batch. It does not show that a product treats or prevents any condition.

FAQ

What does shilajit mean?

Sanskrit dictionaries give shila (rock) plus jit (what conquers or excels), glossed as bitumen or "rock-overpowering".

Which traditions used shilajit?

Ayurveda and Siddha, traditional Persian medicine, Tibetan medicine, Kazakh medicine and Russian and Central Asian folk medicine, under different names.

Is shilajit unique to Nepal?

No. It is documented across mountain ranges including the Himalayas and the Altai, and in Tibetan, Persian and Central Asian sources.

When did scientific study begin?

Chemical and Soviet-era clinical work date from the 1960s to 1980s. The earliest controlled human trial we found is 2016.

References

  1. Wilson E, Rajamanickam GV, Dubey GP, et al. Review on shilajit used in traditional Indian medicine. J Ethnopharmacol. 2011;136(1):1-9. DOI: 10.1016/j.jep.2011.04.033. PMID: 21530631.
  2. Agarwal SP, Khanna R, Karmarkar R, et al. Shilajit: a review. Phytother Res. 2007;21(5):401-405. DOI: 10.1002/ptr.2100. PMID: 17295385.
  3. Shahriari M, Zare F, Nimrouzi M. The curative role of bitumen in traditional Persian medicine. Acta Med Hist Adriat. 2018;16(2):283-292. DOI: 10.31952/amha.16.2.6. PMID: 30488706.
  4. Ding R, Zhao M, Fan J, et al. Mechanisms of generation and exudation of Tibetan medicine shilajit (Zhaxun). Chin Med. 2020;15:65. DOI: 10.1186/s13020-020-00343-9. PMID: 32612671.
  5. Kizaibek M. Research advances of Tasmayi. Zhongguo Zhong Yao Za Zhi. 2013;38(3):443-448. PMID: 23668027.
  6. Aiello A, Fattorusso E, Menna M, et al. Mumijo traditional medicine: fossil deposits from Antarctica. Evid Based Complement Alternat Med. 2011;2011:738131. DOI: 10.1093/ecam/nen072. PMID: 18996940.
  7. Stohs SJ. Safety and efficacy of shilajit (mumie, moomiyo). Phytother Res. 2014;28(4):475-479. DOI: 10.1002/ptr.5018. PMID: 23733436.
  8. Shahjahan M, Islam I. Preliminary evaluation of shilajit as a suspending agent in antacid suspensions. Drug Dev Ind Pharm. 1998;24(11):1109-1112. PMID: 9876568.
  9. Shakurov ASh. Effect of mumie on bone regeneration and blood alkaline phosphatase in experimental fractures of the tubular bones. 1965. PMID: 14348079. Russian-language; abstract-level only.
  10. Rogozkin VD, Tukhtaev T. Effect of mumie preparation on lymphopoiesis in acute radiation sickness. Biull Eksp Biol Med. 1968;65(1):110-111. PMID: 5652273. Russian-language.
  11. Suleimanov I. Effects of mumie on bone regeneration in patients subjected to surgery for osteoarticular tuberculosis. Ortop Travmatol Protez. 1972;33(2):64-66. PMID: 5018936. Russian-language.
  12. Kel'ginbaev NS, Sorokina VA, Stefanidu AG, Ismailova VN. Treatment of long tubular bone fractures with Mumie Assil preparations. Eksp Khir Anesteziol. 1973;18(4):31-35. PMID: 4271714. Russian-language.
  13. Tazhimametov BT, Usmanov MU, Dzhuraev KhA, et al. Effect of mumie on the healing of suppurative wounds. Klin Khir. 1987;(1):51-52. PMID: 3560681. Russian-language.
  14. Agzamov RA, Arifkhanova SI, Vakhidova GA. Mumie as a pathogenetic agent in the treatment of tuberculosis. Probl Tuberk. 1988;(7):49-52. PMID: 3265209. Russian-language.
  15. Ghosal S. Shilajit I: chemical constituents. 1976. PMID: 932958.
  16. Goel RK, Banerjee RS, Acharya SB. Antiulcerogenic and antiinflammatory studies with shilajit. J Ethnopharmacol. 1990;29(1):95-103. PMID: 2345464.
  17. Schepetkin IA, Khlebnikov AI, Ah SY, et al. Characterization and biological activities of humic substances from mumie. J Agric Food Chem. 2003;51(18):5245-5254. PMID: 12926866.
  18. Schepetkin IA, Xie G, Jutila MA, Quinn MT. Complement-fixing activity of fulvic acid from shilajit and other natural sources. Phytother Res. 2009;23(3):373-384. PMID: 19107845.
  19. Biswas TK, Pandit S, Mondal S, et al. Clinical evaluation of spermatogenic activity of processed shilajit in oligospermia. Andrologia. 2010;42(1):48-56. PMID: 20078516.
  20. Pandit S, Biswas S, Jana U, et al. Clinical evaluation of purified shilajit on testosterone levels in healthy volunteers. Andrologia. 2016;48(5):570-575. PMID: 26395129.
  21. Dictionary entries for shilajit (Apte; Shabda-Sagara; Monier-Williams cross-reference), as presented by Wisdom Library. Read 8 October 2026.

Findings above are drawn from published abstracts and dictionary entries; full texts were not reviewed.

Related Reading